Our comprehensive in vitro and in vivo analyses have shown that CCDC25 acts as a crucial regulator of ccRCC cell proliferation, migration, and apoptosis, and its low expression is associated with poor clinical outcomes in ccRCC patients. The gene discussed is CCDC25; the disease is nonpapillary renal cell carcinoma.